Clinical Trial Update: A Phase 2 Study Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial of EDP1815 for mild to moderate plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• EDP1815 (EDP1815)

Snippet

Sponsor: Evelo Biosciences, Inc. | Conditions: Psoriasis, Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2022-12-19